The ability of animals to store and retrieve food caches in the wild requires the integration of biological signals of hunger, satiety and memory. The role of ghrelin in regulating feeding and memory makes ghrelin receptors an important target to shape the required cellular and molecular responses. We investigated the effects of the high ligandindependent activity of the ghrelin receptor on the physiology of excitatory synapses.
Introduction
Ghrelin is a peptide hormone believed to signal meal initiation (1, 2) and is found at the highest concentration in human plasma immediately before each meal (3) . It is mainly secreted by X/A-like cells in the oxyntic glands of the stomach and intestine (4) . Apart from effects on food intake (5) and feeding behavior (6, 7) , ghrelin influences several other physiologic systems. For example, it is well established that ghrelin improves learning and memory (8, 9) , regulates reward through its action on the mesolimbic dopamine system (10) , modulates anxiety- (9) and depressive-like (11) behaviors, and affects long-term fear memory (12) .
The actions of ghrelin are mediated by the growth hormone secretagogue receptor type 1a (GHSR-1a), a G protein-coupled receptor (GPCR), whose activation by ghrelin regulates gene expression, neuronal excitability and AMPA receptor trafficking (8, (13) (14) (15) . In the brain, GHSR-1a is highly expressed in the hypothalamus, pituitary gland and hippocampus (16) and its expression levels increase during fasting (17) (18) (19) .
Interestingly, GHSR-1a displays unusually high constitutive activity, corresponding to approximately 50% of its maximal activity (20) , that results from a natural shift in the equilibrium between its inactive and active conformations (21) , in the absence of ligand.
The ligand-independent GHSR-1a activity plays a role in the control of food intake and regulation of body weight (18, 19, (22) (23) (24) , and in the acquisition of conditioned taste aversion (25) . Human mutations that lead to a selective loss of constitutive activity of GHSR-1a, but that do not interfere with ghrelin-induced activation, are associated with familial short stature (26) (27) (28) . The recently described liver-expressed antimicrobial peptide 2 (LEAP2) is an endogenous antagonist of the ghrelin receptor (29) , which also exhibits inverse agonist activity, blocking ghrelin receptor constitutive activity (30, 31) .
LEAP2 plasmatic levels are lower in fasted states (29, 31) , increase with body mass and blood glucose, and are higher in obesity (31) , in a manner that is opposite to that of plasma acyl-ghrelin. These observations indicate that acyl-ghrelin and LEAP2 bidirectionally control ligand-dependent activity of the ghrelin receptor, and importantly that LEAP2 exerts endogenous control of the ligand-independent activity of the ghrelin receptor, which is physiologically relevant (32) .
Ghrelin receptor knock-out animals display spatial and contextual memory impairments (33, 34) , which can be attributed to the absence of ghrelin-triggered effects, but also to the loss of ligand-independent activity. However, the physiological importance of GHSR-1a constitutive activity for learning and memory has not been described. Here, using a combination of imaging, biochemical and electrophysiological approaches, and behavior analysis, we uncover a role for the constitutive activity of the ghrelin receptor in providing tonic control for the regulation of AMPA receptor traffic, influencing synaptic plasticity in the hippocampus and interfering with learning and memory in vivo. These finding should be taken into account given that inverse agonists of the ghrelin receptor are presently being tested in humans to treat alcohol use disorder (35, 36) .
Results

AMPA-receptor surface and synaptic expression is regulated by ligandindependent activity of the ghrelin receptor
To test whether the constitutive activity of the ghrelin receptor could provide a tonic signal in the hippocampus and regulate AMPA receptor traffic, we evaluated whether inverse agonists of the ghrelin receptor affect the synaptic content of AMPA-type glutamate receptors in cultured hippocampal neurons. We used a newly described blood-brain barrier (BBB) permeable inverse agonist of the ghrelin receptor, AZ12861903 (AZ), which decreases the constitutive activity of the receptor (23) , and also the more widely used [D-Arg 1 ,D-Phe 5 ,D-Trp 7,9 ,Leu 11 ]-substance P (SP-A), a well-established ghrelin receptor inverse agonist which does not cross the BBB (18, 20) . Incubation of hippocampal neurons (15 DIV) with either of these compounds decreased the total cell To test whether the ligand-independent activity of the ghrelin receptor functionally modulates CA3-CA1 hippocampal excitatory transmission, organotypic hippocampal slices were treated with SP-A for 20h, and electrophysiological recordings were performed. The AMPA/NMDA ratio of synaptic responses decreased significantly after treatment with SP-A, compared with control neurons, whereas the ghrelin receptor antagonist [D-Lys 3 ]-GHRP-6 did not affect AMPA/NMDA ratios (Figs. 1E, F), in agreement with low levels of ghrelin in the culture, and a specific role for the ghrelin receptor inverse agonist in inhibiting CA3-CA1 synaptic transmission. Together, these results suggest that the constitutive activity of GHSR regulates AMPA receptor levels and excitatory synaptic transmission under basal conditions. We then silenced the expression of the ghrelin receptor in cultured hippocampal neurons using a short hairpin RNA (shRNA) containing a previously validated sequence (37) and tested for surface levels of GluA1. Knock-down of the ghrelin receptor decreased the levels of surface and synaptic GluA1, which were rescued when the shRNA was co-expressed with an shRNA-insensitive human form of the receptor (hGHS-R1a, Figs. 1G-I and Supplementary Fig. 1N ). Notably, treatment with either SP-A or AZ did not affect the total surface or synaptic levels of GluA1 in neurons where the ghrelin receptor expression was silenced (Figs. 1G-I and Supplementary Fig. 1N ), confirming the specificity of SP-A and AZ in targeting the ghrelin receptor.
Ligand-independent activity regulates AMPA receptor surface mobility
To determine how the ligand-independent activity of the ghrelin receptor may regulate AMPA receptors, we tested for effects on the cell surface diffusion of GluA1 AMPA receptor subunit. We expressed superecliptic pHluorin (SEP)-GluA1 in cultured hippocampal neurons and took advantage of the single particle tracking approach to monitor individual AMPA receptor complexes (Figs. 2A-E). Hippocampal neurons were exposed to SP-A for 1 h and single nanoparticle imaging of SEP-GluA1 was performed thereafter. SP-A exposure significantly increased the surface diffusion of GluA1 (both the mean square displacement and diffusion coefficient were increased, Figs 
Effects of the constitutive activity of the ghrelin receptor on activity-induced synaptic incorporation of AMPA-receptor
We then assessed whether activity-induced synaptic incorporation of AMPA receptors is regulated by the ligand-independent activity of the ghrelin receptor. We used a neuronal culture model of chemical long-term potentiation (cLTP), in which activation of NMDA receptors triggers an increase in the expression of surface synaptic AMPA receptors (38) . In agreement with previous reports, application of glycine, the co-agonist of NMDA receptors, in the absence of Mg 2+ led to a significant increase in the synaptic expression 
Intracellular signaling of ligand-independent activity of the ghrelin receptor
We tested cell signaling pathways downstream of the ghrelin receptor constitutive activity that could result in altered trafficking of AMPA receptors. We found that upon blockade of the ligand-independent activity of the ghrelin receptors in organotypic hippocampal slices there was a decrease in the phosphorylation of GluA1 at Ser845 (Fig. 3A ), a PKA phosphorylation site critical for priming AMPA receptors for synaptic insertion (39) .
Additionally, a decrease in the phosphorylation of CaMKIV ( To test whether the ghrelin receptor constitutive activity contributes to AMPA receptor traffic through effects on GluA1 phosphorylation at Ser845, we evaluated whether SP-A affects the cell surface and synaptic levels of phosphodead and phosphomimetic mutants of GluA1 at Ser 845 (Ser845A and Ser845D, respectively). We found that contrarily to wild-type GluA1, SP-A treatment did not alter the cell surface or synaptic levels of either of these mutants (Figs. 3F-H), suggesting GluA1 phosphorylation at Ser845 as one mechanism through which the constitutive activity of the ghrelin receptor regulates AMPA receptor traffic.
Constitutive activity of the ghrelin receptor is relevant for memory formation
Given the role of the hippocampus and excitatory transmission in spatial memory (40) , and that ghrelin receptor knock-out mice present memory impairments (33, 34) , we tested whether ghrelin receptor constitutive activity plays a role in memory formation by evaluating performance in the novel object recognition test (41) in mice injected with the BBB-permeable inverse agonist of the ghrelin receptor AZ. During the familiarization session, animals were allowed to explore two identical objects for 10 min. After 6 h, one of the objects was replaced with a novel object, and the percentage of time exploring either object was measured (test session, Fig. 4A ). Whereas control animals explored the novel object a higher number of times and for longer, animals treated with the ghrelin receptor inverse agonist prior to the familiarization session did not show a preference for either object, as measured by the number of explorations of each object ( Fig. 4B ) or time spent with each object (Fig. 4C ). To account for changes in motor behavior, before and after drug administration, we also measured total distance travelled by animals in the arena and did not find significant alterations between vehicle-and drug-treated animals ( Supplementary Fig. S3A ).
To test whether the constitutive activity of the ghrelin receptor is relevant for spatial memory, we used the object displacement test (42) Our results indicate that acute blockade of GHSR-1a constitutive activity impairs performance during the novel object recognition task and in the object displacement recognition task, which suggests that tonic activity of the ghrelin receptor is important for learning and memory.
Discussion
The constitutive activity of the ghrelin receptor has been previously described to regulate food intake and body weight (18, 19) , but its involvement in the regulation of hippocampal synaptic transmission and plasticity, memory and learning has not been directly addressed. Here, we provide strong evidence that the ligand-independent activity of the ghrelin receptor regulates AMPA receptors at the synapse and the formation of spatial memories.
We first tested whether two inverse agonists of the ghrelin receptor affect the synaptic content of AMPA receptors, which are critical for synaptic plasticity processes thought to underlie learning and memory (43) . We observed that the GHSR constitutive activity regulates the levels of synaptic GluA1 and GluA2 AMPA receptors in cultured hippocampal neurons, and the AMPA/NMDA ratio in hippocampal organotypic slice cultures. In agreement with these observations, we found a decrease on the synaptic levels of GluA1 upon silencing of the expression of the ghrelin receptor. We also confirmed the specificity of both inverse agonists of the ghrelin receptor, since they showed no effects on GluA1 in neurons depleted of the ghrelin receptor expression.
We further explored how the GHSR constitutive activity impacts the synaptic and surface levels of AMPA-receptors, which are controlled both by exocytic/endocytic receptor traffic and by the recruitment to the synapse of extrasynaptic receptors preexisting at the neuronal plasma membrane (44) . Using single particle imaging, we evaluated whether the ghrelin receptor ligand-independent activity affects the cell surface diffusion of AMPA receptors, which is critically important for synaptic plasticity underlying learning and memory (45) . We observed that blocking ghrelin receptor constitutive activity enhanced the mobility of synaptic GluA1 and GluA2 AMPAreceptors, and decreased the residence of GluA1 and GluA2 at synapses.
Ligand-independent activity of the ghrelin receptor may be required for synaptic plasticity processes. Indeed, using a neuronal culture model of cLTP we observed that both inverse agonists of the ghrelin receptor block LTP, as measured by the synaptic accumulation of GluA1. These observations suggest that the high constitutive signaling of the ghrelin receptor generates a signaling set-point to regulate the levels of synaptic AMPA receptors and synaptic plasticity in the hippocampus. Our data further indicate that this control is produced through the phosphorylation of GluA1 at serine 845.
Phosphorylation of GluA1 serine 845 regulates extrasynaptic membrane trafficking of GluA1, and primes AMPA receptors for synaptic insertion upon the induction of synaptic plasticity (39) . Interestingly, phosphorylation of this site is also required for retention of spatial learning (46) .
In order to assess the physiologic relevance of the ligand-independent activity of the ghrelin receptor we tested the effect of its blockade on the memory for object novelty and location. We observed that blocking ligand-independent activity of the ghrelin receptor impairs memory assessed by the novel object recognition and object displacement recognition tests. This effect is in agreement with the observation that ghrelin receptor knockout mice perform poorly in memory tests (33, 34) , and suggests a clear role in memory for the unusually high constitutive activity of the ghrelin receptor, an intrinsic feature of this receptor (47) .
Besides signaling in response to ghrelin, and in the absence of the ligand, the ghrelin receptor has recently been shown to modulate dopamine signaling through heterodimerization with dopamine receptors DRD1 and DRD2 (48, 49) . In the hippocampus, GHSR-1a and DRD1 form heteromers that are activated by DRD1 agonists to induce intracellular Ca 2+ mobilization, activation of early synaptic plasticity markers, and to modulate memory (49) . Importantly, the dopamine-induced effect on Ca 2+ signaling is independent of the constitutive activity of the ghrelin receptor in the GHSR-1a:DRD1 complex (49) . This suggests that the role of the constitutive activity of the ghrelin receptor on memory here described runs parallel to the effects of dopamine on memory through the GHSR-1a:DRD1 complex.
The GHSR-1a constitutive activity has also been shown to reduce presynaptic Cav2 currents and GABA release in hypothalamic and hippocampal neurons (50, 51) , by reducing the cell surface expression of Cav2 channels (52) . Our results complement this observation, but work should be done to explore how the effects of the constitutive activity of the ghrelin receptor on the inhibitory and excitatory systems contribute to memory formation.
It was recently reported that the melanocortin receptor accessory protein 2 (MRAP2) controls GHSR-1a signaling by inhibiting its constitutive activity, as well as by increasing its G protein-mediated signaling and blocking the recruitment and signaling of β-arrestin elicited by ghrelin binding (53) . Disruption of the gene for MRAP2 has been associated with obesity in animal models and humans (54) . MRAP2 mRNA has low expression in the hippocampus of both animals (54, 55) and humans (56), which suggests that constitutive activity of the ghrelin receptor is unimpeded in this region and is thus more likely to have an influence in hippocampal excitatory synapse protein dynamics and hippocampus-dependent behavior.
Recent evidence suggests that the constitutive activity of the receptor is endogenously regulated by the plasmatic levels of LEAP2 (49) , which are proportional to the levels of adiposity and blood glucose (31) , and also potentially by the levels of expression of the ghrelin receptor (18) , which in turn change according to the animal´s feeding status (17, 18) . Therefore, our observations support a physiological mechanism in which the internal metabolic state of animals exerts control over cognitive processes.
Finally, the role of the ghrelin receptor constitutive activity reported in this work should be taken into account when considering its inverse agonists as anti-obesity agents (57), or their use for the treatment of alcohol use disorder (35, 36) . The novel object recognition task was adapted from Leger and colleagues (41) , the object displacement test was adapted from Oliveira and colleagues (42) and the elevated plus maze was performed according to (58) . These tests are described in more detail in SI Materials and Methods.
Materials and Methods
Animals and Behavior
Immunocytochemistry
For labeling surface GluA1-containing AMPA receptors, live neurons were incubated for 10 min at room temperature using an antibody against an extracellular epitope in the GluA1 N-terminus diluted in conditioned neuronal culture medium or extracellular solution (used for chemical LTP). Neurons were then fixed and stained as previously described (59) . For labeling GluA2-containing AMPA receptors, neurons were fixed and then incubated overnight with an anti-GluA2 antibody diluted 1:100 in 3%BSA/PBS, at 4°C. Neurons were then stained as previously described (59) .
Quantitative imaging analysis
Imaging was performed on a Zeiss Axio Observer Z1 microscope using a Plan Apochromat 63×/1.4 NA oil objective, and an AxioCam HRm CCD camera. Images were quantified using image analysis software (ImageJ). For quantification, sets of cells were cultured and stained simultaneously, and imaged using identical settings. The region of interest was randomly selected avoiding primary dendrites, and dendritic length was measured using MAP2 staining. Measurements were performed in 2-5 independent preparations, and at least 7 cells per condition were analyzed for each preparation.
Quantitative imaging quantification was performed as previously described (59) .
Statistical analysis
Statistical differences were calculated according to non-parametric tests in most cases;
Mann-Whitney test was used to compare statistical differences between any two groups.
Comparisons between multiple groups were performed with the Kruskal-Wallis analysis of variance followed by Dunn's multiple Comparison test or with 2-way ANOVA with Bonferroni test for correction of multiple comparisons.
Additional details are available in SI Materials and Methods. mg/kg AZ immediately after. Injected animals were returned to the homecage for 10 min before returning to the arena where two different objects were placed in a specific location. Mice were allowed to explore the objects for 6 mins (familiarization), and this session was repeated 3 times with 3 min interval between each repetition. After 24 h, the animals were returned to the arena, where one of the objects was placed in a new location, and were allowed to explore for 6 min. 
Figures and Figure legends
Supplemental Materials and Methods:
Behavior The novel object recognition task was adapted from Leger and colleagues (1). This task consisted of 3 phases: In a first phase the animals freely explored the empty open-field arena for 10 min (habituation phase). Twenty four hours after, the animals were allowed to explore two similar, symmetrically disposed objects, for 10 min. Ten minutes before this phase the animals were submitted to intraperitoneal injection of either the drug or the vehicle, and stayed in an empty transport cage before entering the training phase.
Six hours after the training phase, the animals were exposed to 2 objects located in the same positions as previously, but this time one of the objects was substituted by a new object that the animal had not contacted previously (test phase).
The object displacement test was adapted from Oliveira and colleagues (2) . The test took place during 2 days. During the first day the animals were allowed to explore an empty open-field for 6 min (habituation phase). Immediately after, the animals were intraperitoneally injected with the inverse agonist of the ghrelin receptor or its respective vehicle and placed in their homecage. After 10 minutes, the animals explored two different objects placed in a specific location of the open field for 6 minutes (training phase). The animals were then returned to their homecage and waited for 3 minutes.
Two more similar training phases were conducted, with a 3 minute waiting period in between. On the next day, the animals returned to the open field, where one of the objects was placed in a new location, and were allowed to explore the objects for 6 minutes (test phase).
The objects and their positions were randomized for both tests. The used objects correspond to the described by Leger and colleagues (1) . The arena and the objects were carefully cleaned before running each animal and in between phases. The test was conducted at a room temperature of 23°C and 15 lux at the center of the arena (homogenously distributed light). Videos of the test were acquired using Noldus Ethovision software and scoring was performed blinded to treatment of the animals, using Noldus Observer.
Elevated plus maze was performed with a maze made in-house according to previously described specifications (3) , and using an adapted protocol (4) . Animals were weighted and injected with the corresponding dose of inverse agonist or vehicle 10 min before starting the test, and stayed in an empty transport cage. The test started by putting the animals in the central part of the maze with the nose aligned with the closed arms, and run for 10 min. The test was conducted under 100 lux at the center of the arena. The arena was carefully cleaned before and after each run. Videos of the test were acquired and automatically quantified using Noldus Ethovision.
Materials
The GHS-R1a inverse agonist [D-Arg 1 ,D-Phe 5 ,D-Trp 7,9 ,Leu 11 ]-substance P (SP-A) was purchased from Bachem (Bubendorf, Switzerland), the AZ12861903 (AZ) GHS-R1a inverse agonist was kindly provided by AstraZeneca. The GHS-R1a agonist MK-0677 was purchased from Axon Medchem (Groningen, The Netherlands). The GHS-R1a antagonist [D-Lys 3 ]-GHRP-6, TTX, and picrotoxin were purchased from Tocris Bioscience (Bristol, UK). The anti-Tubulin antibody was purchased from Sigma-Aldrich (Sintra, Portugal); the anti-Akt, anti-P-Ser473(Akt), anti-PSD95 (rabbit), and anti-CaMKIV antibodies were obtained from Cell Signaling (Danvers, MA, USA); the anti-GluA1, anti-GluA2, anti-P-Ser845(GluA1), anti-P-Ser239/240 (Stargazin) and anti-VGluT1 antibodies were from Millipore (Madrid, Spain); the anti-MAP2 antibody was from Abcam (Cambridge, UK), the anti-P-S831(GluA1) antibody was from Tocris Bioscience (Bristol,UK), the anti-PSD95 (mouse) antibody was from Affinity BioReagents (Golden, USA), and the anti-P-Thr196 (CaMKIV) antibody was from Santa Cruz Biotechnology Inc (Santa Cruz, CA); the anti-GFP (rabbit) antibody was from MBL International (Woburn, USA) and the anti-GFP (mouse) antibody was from Roche (Amadora, Portugal).
Quantum dots (QDs) 655 Goat F(ab')2 anti-mouse IgG conjugate (H + L) were purchased from Invitrogen (Barcelona, Spain). The antibody for the N-terminus of GluA1 was a kind gift from Dr. Andrew Irving (University College Dublin). All other reagents were purchased from Sigma-Aldrich (Sintra, Portugal), Fisher Chemicals or from Merck (Darmstadt, Germany) unless specified otherwise.
DNA constructs
The GFP-tagged GHS-R1a construct (5) was a kind gift from Dr. Helen Wise (The Chinese University of Hong Kong) and SEP-GluA1 was generously provided from Helmut Kessels (Netherlands Institute for Neuroscience). For the generation of the short hairpin interfering RNA construct targeting the ghrelin receptor, a previously described and validated sequence (6) was used. Complementary oligonucleotides, each containing a unique 19-nt sequence derived from within the target mRNA transcripts of ghsr1a gene (NM_032075) targeting nucleotides 79-96 (GACTCACTGCCTGACGAAC) (6), were annealed and subcloned into the HpaI/XhoI sites of the U6 promoter-driven short hairpin RNA expression vector pLentiLox3.7(CMV)EGFP, which co-expresses EGFP under the CMV promoter. The control shRNA that targets firefly luciferase was described previously (7) . Homer1C-DsRed and Homer1C-GFP were previously described (8) .
Application of GHS-R1a agonists and antagonists
Hippocampal organotypic slices (6 DIV) were treated with the GHS-R1a inverse agonist All the injected solutions were prepared in sterile conditions. The drug and vehicle were injected intraperitoneally at volumes of 100-150 µl. The dose of 100 mg/kg was based on previously described doses by McCoull and colleagues (9) .
Neuronal and slice cultures
Primary cultures of rat hippocampal neurons were prepared as previously described (10) .
Hippocampal slices were prepared from young Wistar rats of either sex (postnatal day 5-6) as previously described (11) .
Neuron transfection
DNA constructs [Luciferase shRNA-GFP, GHS-R1a shRNA-GFP (Knock-down), hGHS-R1a (rescue), SEP-GluA1, Homer1C-DsRed and Homer1C-GFP] were expressed in primary cultures of hippocampal neurons at 9 DIV using an adapted calcium phosphate transfection protocol (12), as previously described (10) .
Electrophysiology
Voltage-clamp whole-cell recordings were performed stimulating Schaffer collateral fibers and recording evoked synaptic responses from CA1 pyramidal neurons at different holding potentials. The AMPA/NMDA ratios were calculated by acquiring AMPA receptor responses at -60 mV and NMDA receptor responses at +40 mV at a latency at which AMPAR responses were fully decayed (60 ms after stimulation). Picrotoxin (100 μM) was present in the external solution to block the GABAA receptor responses. The recording chamber was perfused with external solution (in mM: 119 NaCl, 2.5 KCl, 1 NaH2PO4, 11 glucose, 26 NaHCO3, 4 MgCl2, 4 CaCl2 and 0.004 2-chloroadenosine, at pH 7.4), and was gassed with 5% CO2/ 95% O2. Patch recording pipettes (3-6 M Ω) were filled with internal solution (in mM: 115 CsMeSO3, 20 CsCl, 10 HEPES, 2.5 MgCl2, 4 Na2ATP, 0.4 Na3GTP, 10 sodium phosphocreatine and 0.6 EGTA, at pH 7.25). Synaptic responses were evoked with bipolar electrodes using single-voltage pulses (200 μs, up to 20 V).
The stimulating electrodes were placed over Schaffer collateral fibers between 300 and 500 μm from the CA1 recorded cells. Synaptic responses were averaged over 50 trials.
Whole-cell recordings were carried out with a Multiclamp 700A amplifier (Molecular dendritic regions over up to 30 min total experimental time. QDs fixed on the coverslip allowed us to compensate mechanical drifts of the stage.
Quantum dots Tracking and Analysis
The tracking of single QDs was performed with homemade software based on Matlab (Mathworks Inc., Natick, USA). Single QDs were identified by their diffraction limited signals and their blinking fluorescent emission. The trajectory of a QD tagged receptor could not be tracked continuously due to the random blinking events of the QDs. When the positions before and after the dark period were compatible with borders set for maximal position changes between consecutive frames and blinking rates, the subtrajectories of the same receptor were reconnected. The values were determined empirically: 2-3 pixels (0.32-0.48 μm) for maximal position change between two frames and maximal dark periods of 25 frames (1.25 s). MSD curves were calculated for reconnected trajectories of at least 20 frames. The QDs were considered synaptic if colocalized with Homer dendritic clusters for at least five frames. Diffusion coefficients were calculated by a linear fit of the first 4-8 points of the mean square displacement (MSD) plots versus time depending on the length of the trajectory within a certain compartment. The resolution limit for diffusion was 0.0075 μm 2 /s as determined by (15) , whereas the resolution precision was ∼40 nm. Statistical values are given as mean ± SEM or medians ± 25%/75% interval, if not stated otherwise. Statistical significances were performed using GraphPad Prism software. Non-Gaussian distributed data sets were tested by Mann-Whitney t-test. Indications of significance correspond to p values < 0.05 ( * ), p<0.01 ( * * ), and p <0.001 ( * * * ).
Biochemistry
Protein extracts were prepared in lysis buffer [10 mM HEPES (pH 7.4), 150 mM NaCl, 10 mM EDTA, 1% (v/v) Triton X-100 supplemented with 1 mM DTT, 0.1 mM
